查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1881357

全球乳房X光摄影系统市场：依产品类型、模式、最终用户和地区划分 - 市场规模、行业趋势、机会分析和预测（2025-2033）

Global Mammography Systems Market: By Product Type, Modality, End User, and Region - Industry Dynamics, Market Size, Opportunity and Forecast for 2025-2033
出版日期: | 出版商: Astute Analytica | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

近年来，乳房X光摄影系统市场经历了强劲成长，反映出全球对乳癌早期检测和改进诊断技术的日益关注。 2024年，该市场价值约为29.832亿美元，显示全球对乳房X光摄影系统的需求强劲。预计这一成长趋势将在未来十年持续，到2033年达到57.1951亿美元。 2025年至2033年的复合年增长率为7.5%，凸显了该产业的扩张和发展趋势。

推动这一强劲市场成长的关键因素有很多。其中一个主要推动因素是全球乳癌发生率的上升。由于乳癌仍然是女性最常见和最致命的癌症之一，因此对早期检测的日益重视正在推动对高效乳房X光摄影系统的需求。早期筛检和诊断对于改善患者预后至关重要，因此乳房X光检查已成为全球癌症治疗过程中不可或缺的工具。

市场趋势

乳房X光系统市场竞争激烈，主要全球企业包括Hologic、GE医疗、西门子医疗和富士胶片控股等。数位成像、3D乳房X光检查（断层合成）和人工智慧辅助诊断系统等领域的持续技术创新极大地推动了这种竞争格局。

持续的技术创新和市场活跃的一个显着例子是，全球医疗技术领导者西门子医疗于2025年11月在泰国推出该系统，进一步巩固了其致力于改善乳腺癌早期检测的承诺。该系统代表了成像技术的重大进步，提高了诊断准确性和患者舒适度。

同时，慈善捐款也为乳房X光技术的进步做出了贡献。2025年10月，拿骚大学医学中心 (NUMC) 收到一笔100万美元的匿名捐款，用于购买一台新的3D乳房X光机和骨密度仪。这笔资金的注入使NUMC能够加强其诊断基础设施。

为了进一步展现市场的活力，2025年7月，印度医疗技术领域的先驱企业BPL医疗技术公司宣布与知名的放射学和癌症治疗解决方案提供商Panacea医疗技术公司建立战略合作伙伴关係。此次合作旨在透过Panacea在印度各地广泛的诊断中心、妇科医院和政府医疗机构网络，提供先进的乳房X光解决方案。

核心成长驱动因子

乳房X光系统市场正日益受到超越传统2D基本设备的先进技术的驱动。数位乳房断层合成（DBT），也称为3D乳房X光摄影，已成为已开发国家公认的标准诊疗技术。 DBT 的广泛应用主要归功于其优于传统二维乳房X光摄影的临床表现。临床研究表明，DBT 在检测浸润性癌症方面更为有效，能够实现早期诊断并改善患者预后。

新机遇

将乳房X光摄影影像用于机会性心血管疾病筛检的创新应用正在成为乳房X光摄影系统市场的一个重要新机会。传统上，乳房X光摄影几乎完全专注于乳癌的检测。然而，人工智慧 (AI) 的最新进展正在开闢新的途径，利用现有的乳房X光摄影影像来评估其他重大健康问题的风险因素。具体而言，AI 演算法现在可以分析乳房X光照片上的乳房动脉钙化 (BAC)。 BAC 是公认的与心血管疾病风险增加相关的标记。这项功能将常规乳房X光摄影转变为双用途诊断工具，无需额外检查即可提供有关患者心臟健康的宝贵资讯。

优化障碍

儘管乳房X光检查作为早期乳癌检测的重要工具日益重要，但世界许多地区对乳房X光检查的认知仍然不足。这种认知差距严重阻碍了乳房X光检查系统的普及和广泛应用，尤其是在发展中和欠发达地区。在这些地区，许多人并不了解定期乳癌筛检的好处，或对筛检程序有误解，这限制了需求并减缓了市场扩张。如何向大众普及乳房X光检查的重要性仍然是更广泛地推广和利用乳房X光检查的一大障碍。

目录

第一章：研究架构

  • 研究目标
  • 产品概述
  • 市场区隔

第二章：研究方法

  • 质性研究
    • 一手和二手资料来源
  • 量化研究
    • 一手和二手资料来源
  • 依地区划分的原始调查受访者
  • 研究假设
  • 市场规模估算
  • 资料三角验证

第三章：摘要整理：全球乳房X光摄影系统市场

第四章：全球乳房X光摄影系统市场概述

  • 产业价值链分析
    • 原料供应商
    • 製造商
    • 经销商
    • 终端用户
  • 行业展望
    • 乳房X光系统市场概述
    • 乳房X光检查人口统计分析
  • 波特五力分析
    • 供应商议价能力
    • 买方议价能力
    • 替代品威胁
    • 新进入者威胁
    • 竞争强度
  • 市场动态与趋势
    • 成长推动因素
    • 阻碍因素
    • 挑战
    • 主要趋势
  • 新冠疫情对市场成长的影响评估趋势
  • 市场成长与展望
    • 市场收入估计与预测（2020-2033）
    • 价格趋势分析
  • 竞争格局概览
    • 市场集中度
    • 公司市占率分析（价值，2024）
    • 竞争格局图
    • 促销行销策略与独特卖点 (USP)

第五章：全球乳房X光摄影系统市场依产品类型分析

  • 主要发现
  • 市场规模及预测（2020-2033）
    • 模拟乳房X光摄影系统
    • 数位乳房X光摄影系统

第六章：全球乳房X光摄影系统市场分析模式

  • 主要发现
  • 市场规模及预测，2020-2033 年
    • 便携式乳房X光摄影系统
    • 非便携式乳房X光摄影系统

第七章：全球乳房X光摄影系统市场依最终用户划分的分析

  • 主要见解
  • 市场规模及预测，2020-2033 年
    • 住院机构
    • 门诊手术中心

第八章：全球乳房X光摄影系统市场依地区划分的分析

  • 主要见解
  • 市场规模及预测，2020-2033 年
    • 北美
    • 欧洲
    • 亚太地区
    • 中东和非洲
    • 南美洲

第九章：北美乳房X光摄影系统市场分析

第十章：欧洲乳房X光摄影系统市场分析

第十一章：亚太地区乳房X光摄影系统市场分析

第十二章：中东与非洲乳房X光摄影系统市场分析

第十三章：南美洲乳房X光摄影系统市场分析

第十四章：公司简介

  • Allengers Medical Systems Limited
  • 富士软片控股株式会社
  • 通用电气公司
  • Hologic Incorporated
  • 柯尼卡美乐达株式会社
  • 皇家飞利浦公司（飞利浦医疗保健）
  • Metaltronica SPA
  • Planmeca OY
  • 西门子股份公司
  • 东芝公司
  • 其他主要参与者
简介目录
Product Code: AA0622265

The mammography systems market has experienced robust growth in recent years, reflecting a growing global emphasis on early breast cancer detection and improved diagnostic technologies. In 2024, the market was valued at approximately US$ 2,983.2 million, underscoring the significant demand for mammography systems worldwide. This upward trajectory is expected to continue over the coming decade, with projections estimating the market will reach an impressive value of US$ 5,719.51 million by 2033. The compound annual growth rate (CAGR) for the period 2025-2033 is 7.5%, highlighting the expansion and evolving dynamics of the industry.

Several key factors are driving this strong market growth. One of the primary contributors is the rising prevalence of breast cancer globally. As breast cancer remains one of the most common and deadly cancers among women, there is an increasing emphasis on early detection, which fuels the demand for effective mammography systems. Early screening and diagnosis are critical for improving patient outcomes, making mammography an indispensable tool in cancer care pathways around the world.

Noteworthy Market Developments

The mammography systems market is marked by intense competition among several key global players, including Hologic, GE HealthCare, Siemens Healthineers, and Fujifilm Holdings. This competitive environment is largely fueled by continuous technological innovation, especially in areas such as digital imaging, 3D mammography (tomosynthesis), and AI-assisted diagnostic systems.

A notable example of ongoing innovation and market activity occurred in November 2025 when Siemens Healthineers, a global leader in medical technology, reinforced its dedication to improving early breast cancer detection by launching the MAMMOMAT B.brilliant in Thailand. This next-generation 3D mammography system represents a significant advancement in imaging technology, offering enhanced diagnostic accuracy and patient comfort.

In parallel, philanthropic support has also played a role in advancing mammography capabilities. In October 2025, Nassau University Medical Center (NUMC) received an anonymous donation of $1 million, which was allocated toward acquiring new 3D mammography and bone density scanning systems. This infusion of funds enables NUMC to upgrade its diagnostic infrastructure.

Further illustrating the dynamic nature of the market, July 2025 saw BPL Medical Technologies, a pioneer in the Indian medical technology sector, announce a strategic alliance with Panacea Medical Technologies, a well-established name in radiology and cancer care solutions. This partnership aims to deliver advanced mammography solutions through Panacea's extensive network of diagnostic centers, women's health hospitals, and government health institutions across India.

Core Growth Drivers

The mammography systems market is increasingly being driven by advanced technologies that go beyond the traditional basic 2D units. Among these, Digital Breast Tomosynthesis (DBT), also known as 3D mammography, has emerged as the undisputed standard of care in developed countries. The widespread adoption of DBT is largely attributed to its superior clinical performance compared to conventional 2D mammography. Clinical studies have demonstrated that DBT is more effective at detecting invasive cancers, which leads to earlier diagnosis and improved patient outcomes.

Emerging Opportunity Trends

A significant and emerging opportunity within the mammography systems market lies in the innovative use of mammograms for opportunistic screening of cardiovascular disease. Traditionally, mammography has been focused almost exclusively on the detection of breast cancer. However, recent advancements in artificial intelligence (AI) have opened new avenues for leveraging existing mammogram images to assess risk factors for other serious health conditions. Specifically, AI algorithms can now analyze breast arterial calcification (BAC), which appears on mammograms and is a well-established marker associated with increased risk of cardiovascular disease. This capability transforms routine mammography screenings into a dual-purpose diagnostic tool, offering valuable insights into a patient's heart health without any additional procedures.

Barriers to Optimization

Despite the increasing prominence of mammography as a crucial tool for the early detection of breast cancer, there remains a persistent lack of knowledge about mammography frameworks in many parts of the world. This gap in awareness significantly hinders the adoption and growth of mammography systems, particularly in developing and underdeveloped regions. Many individuals in these areas are either unaware of the benefits of regular breast cancer screening or hold misconceptions about the procedure, which limits demand and slows market expansion. The challenge of educating populations about the importance of mammography remains a critical obstacle to broader acceptance and utilization.

Detailed Market Segmentation

In terms of product type, analogue mammography systems hold a significant market share, accounting for over 66.20 percent. As a result of analogue technology being widely available and supported by established infrastructure, it has been the gold standard for screening breast cancer for decades. There are still many healthcare facilities that use analogue mammography systems, especially in regions where budget constraints or technological limitations exist.

By End User, Hospitals serve as the financial backbone of the mammography systems market, commanding a dominant market share of approximately 68.90%. Their prominence stems from their role as comprehensive healthcare providers, offering a full spectrum of services from initial diagnosis to treatment within inpatient settings. This all-encompassing approach allows hospitals to generate the highest revenue in the mammography market, as patients often rely on these facilities for both preventive screenings and subsequent medical care.

By Modality, Portable mammography systems have emerged as a transformative force within the mammography systems market, currently commanding a significant market share of over 53.80%. Their rapid growth and widespread adoption are reshaping how breast cancer screening services are delivered, particularly by overcoming traditional barriers related to location, accessibility, and socioeconomic status. Unlike fixed mammography units, portable systems offer the unique advantage of mobility, allowing healthcare providers to bring essential diagnostic services directly to patients who might otherwise face difficulties accessing care.

Segment Breakdown

By Product Type:

  • Analog Mammography Systems
  • Digital Mammography Systems

By Modality:

  • Portable Mammography Systems
  • Non-Portable Mammography Systems

By End User:

  • Impatient Settings
  • Ambulatory Surgical Centers

By Region:

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America holds the largest share of the global mammography systems market, a position that reflects several key factors driving the region's dominance. One of the primary reasons behind this leadership is the high level of patient awareness regarding breast cancer screening and early detection. This awareness translates into widespread demand for mammography services, encouraging healthcare providers to invest in the latest diagnostic technologies.
  • The mammography systems market in North America is also defined by considerable capital investment in state-of-the-art diagnostic equipment. Healthcare providers allocate significant resources to procure advanced mammography systems that offer enhanced imaging capabilities, faster processing, and improved patient comfort. These investments are necessary to meet the demands of a large screening population and to keep pace with technological advancements that continually refine diagnostic precision.

Leading Market Participants

  • Allengers Medical Systems Limited
  • Fujifilm Holding Corporation
  • General Electric Company
  • Hologic Incorporated
  • Konica Milota Incorporated
  • Koninklijke Philips N.V. (Philips Healthcare)
  • Metaltronica SPA
  • Planmeca OY
  • Siemens Aktiengesellschaft
  • Toshiba Corporation
  • Other Prominent Players

Table of Content

Chapter 1. Research Framework

  • 1.1 Research Objective
  • 1.2 Product Overview
  • 1.3 Market Segmentation

Chapter 2. Research Methodology

  • 2.1 Qualitative Research
    • 2.1.1 Primary & Secondary Sources
  • 2.2 Quantitative Research
    • 2.2.1 Primary & Secondary Sources
  • 2.3 Breakdown of Primary Research Respondents, By Region
  • 2.4 Assumption for the Study
  • 2.5 Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Mammography Systems Market

Chapter 4. Global Mammography Systems Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Material Provider
    • 4.1.2. Manufacturers
    • 4.1.3. Distributor
    • 4.1.4. End user
  • 4.2. Industry Outlook
    • 4.2.1. Overview of Mammography Systems Market
    • 4.2.2. Demographic analysis under Mammography
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of Substitutes
    • 4.3.4. Threat of New Entrants
    • 4.3.5. Degree of Competition
  • 4.4. Market Dynamics and Trends
    • 4.4.1. Growth Drivers
    • 4.4.2. Restraints
    • 4.4.3. Challenges
    • 4.4.4. Key Trends
  • 4.5. Covid-19 Impact Assessment on Market Growth Trend
  • 4.6. Market Growth and Outlook
    • 4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2020 - 2033
    • 4.6.3. Price Trend Analysis
  • 4.7. Competition Dashboard
    • 4.7.1. Market Concentration Rate
    • 4.7.2. Company Market Share Analysis (Value %), 2024
    • 4.7.3. Competitor Mapping
    • 4.7.4. Promotional Marketing Strategies and USPs

Chapter 5. Global Mammography Systems Market Analysis, By Product Type

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 5.2.1. Analog Mammography Systems
    • 5.2.2. Digital Mammography Systems

Chapter 6. Global Mammography Systems Market Analysis, By Modality

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 6.2.1. Portable Mammography Systems
    • 6.2.2. Non-Portable Mammography Systems

Chapter 7. Global Mammography Systems Market Analysis, By End User

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 7.2.1. Impatient Settings
    • 7.2.2. Ambulatory Surgical Centers

Chapter 8. Global Mammography Systems Market Analysis, By Region

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 8.2.1. North America
      • 8.2.1.1. The U.S.
      • 8.2.1.2. Canada
      • 8.2.1.3. Mexico
    • 8.2.2. Europe
      • 8.2.2.1. Western Europe
        • 8.2.2.1.1. The UK
        • 8.2.2.1.2. Germany
        • 8.2.2.1.3. France
        • 8.2.2.1.4. Italy
        • 8.2.2.1.5. Spain
        • 8.2.2.1.6. Rest of Western Europe
      • 8.2.2.2. Eastern Europe
        • 8.2.2.2.1. Poland
        • 8.2.2.2.2. Russia
        • 8.2.2.2.3. Rest of Eastern Europe
    • 8.2.3. Asia Pacific
      • 8.2.3.1. China
      • 8.2.3.2. India
      • 8.2.3.3. Japan
      • 8.2.3.4. South Korea
      • 8.2.3.5. Australia & New Zealand
      • 8.2.3.6. ASEAN
      • 8.2.3.7. Rest of Asia Pacific
    • 8.2.4. Middle East & Africa
      • 8.2.4.1. UAE
      • 8.2.4.2. Saudi Arabia
      • 8.2.4.3. South Africa
      • 8.2.4.4. Rest of MEA
    • 8.2.5. South America
      • 8.2.5.1. Argentina
      • 8.2.5.2. Brazil
      • 8.2.5.3. Rest of South America

Chapter 9. North America Mammography Systems Market Analysis

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 9.2.1. By Product Type
    • 9.2.2. By Modality
    • 9.2.3. By End User
    • 9.2.4. By Country

Chapter 10. Europe Mammography Systems Market Analysis

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 10.2.1. By Product Type
    • 10.2.2. By Modality
    • 10.2.3. By End User
    • 10.2.4. By Country

Chapter 11. Asia Pacific Mammography Systems Market Analysis

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 11.2.1. By Product Type
    • 11.2.2. By Modality
    • 11.2.3. By End User
    • 11.2.4. By Country

Chapter 12. Middle East and Africa Mammography Systems Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 12.2.1. By Product Type
    • 12.2.2. By Modality
    • 12.2.3. By End User
    • 12.2.4. By Country

Chapter 13. South America Mammography Systems Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 13.2.1. By Product Type
    • 13.2.2. By Modality
    • 13.2.3. By End User
    • 13.2.4. By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 14.1. Allengers Medical Systems Limited
  • 14.2. Fujifilm Holding Corporation
  • 14.3. General Electric Company
  • 14.4. Hologic Incorporated
  • 14.5. Konica Milota Incorporated
  • 14.6. Koninklijke Philips N.V. (Philips Healthcare)
  • 14.7. Metaltronica SPA
  • 14.8. Planmeca OY
  • 14.9. Siemens Aktiengesellschaft
  • 14.10. Toshiba Corporation
  • 14.11. Other Prominent Players